fashion -WSS

fashion

author：knowledge 2025-10-04 06:24:58 - browse：233

LONDON — AstraZeneca said on Monday that a new lung cancer treatment outperformed standard-of-care chemotherapy in a trial, but investors found the results less impressive than anticipated, sending company shares down in early trading.

Based on an interim analysis of a Phase 3 trial, the company said that the drug, datopotamab deruxtecan, led to improvement in progression-free survival in patients non-small cell lung cancer, a primary endpoint of the study. There was also a positive early trend on overall survival, with Susan Galbraith, AstraZeneca’s oncology leader, describing the results as “compelling evidence for the potential role” that the drug could play for patients.

But investors had been hoping for a clearer signal of benefit. Analysts noted that despite the success in progression-free survival, it was not described as a “clinically meaningful” improvement, which, as J.P. Morgan analysts wrote, “we believe the market would have liked to have seen.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： Manchin plays down potential 3rd

leisure time

WSS

Novo Nordisk touts Wegovy study, but still struggling with supply

Idaho college killings prosecutors challenge defense's grand jury claims

Biden administration sends mixed signals on US soldier who crossed into North Korea

Lack of darker skin in textbooks, journals harms patients of color

Patients, digital health players weigh in on FTC's data privacy plan

Illumina slashes 2023 revenue projections yet again

explore

fashion

focus

State Dept. review finds Biden bears some blame for Afghanistan failures

Patients, digital health players weigh in on FTC's data privacy plan

Malaria cases in Florida and Texas: Here’s what you need to know

After Optum profits sink, UnitedHealth makes changes

BioMarin wins approval for gene therapy to treat hemophilia A

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Duchenne breakthrough therapy leaves behind pioneering families

Aspartame and sugar

Sports medicine is finally prioritizing gender equality

Judge sides with young activists in first

hotspot

Maui wildfire now ranks as the fifth

Maui wildfire now ranks as the fifth

Dozens dead from Maui wildfires: What we know about the victims

Montana youths win climate lawsuit against state for promoting fossil fuels

Dozens dead from Maui wildfires: What we know about the victims

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

focus

explore

leisure time

hotspot